New Broad Spectrum Fluoroquinolone From Animalcare

Enrocare® solution for injection is now available from Animalcare presented in three strengths. A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats,whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. Animalcare has priced Enrocare competitively and, in addition, the range has been launched with three offers “buy one get one free on the 50 and 100mg/ml” and a “ buy two get one free offer” on the 25mg/ml pack size. These offers will last for four months until the end of September. Enrocare is a broad spectrum fluoroquinolone antimicrobial that is highly effective in the treatment of a wide range of conditions. It is ready to use and easy to inject with excellent tissue penetration. In the case of dogs and cats just a single daily dose is needed. In cattle, Enrocare 50mg/ml, given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). Its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia. Animalcare has historically focussed on products for companion animals, however, following this launch, the company will be bringing further new products on to the market for use in large animals. “The recent successful launch of Cephacare flavour raised Animalcare’s profile as a supplier of mainstream antibiotics and this our latest addition further enhances our profile by offering excellent efficacy at an attractive price” says Tony Liepman, Animalcare Market Manager. “We have a growing range of tried and trusted affordable antibiotics. Enrocare will soon be followed by other new products”, he added.

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards